Predictive value of co-existing genetic alterations and tumor mutation burden for patients with completely resected non-small cell lung cancer harboring EGFR mutation: Biomarker analysis of phase III IMPACT study

被引：0
|
作者：
Ikeda, Satoshi
Tsuboi, Masahiro
Sakai, Kazuko
Misumi, Toshihiro
Akamatsu, Hiroaki
Iwamoto, Yasuo
Sakakura, Noriaki
Nakamura, Atsushi
Ohde, Yasuhisa
Hayashi, Hidetoshi
Okishio, Kyoichi
Okada, Morihito
Yoshino, Ichiro
Okami, Jiro
Takahashi, Kazuhisa
Ikeda, Norihiko
Mitsudomi, Tetsuya
Tada, Hirohito
Nakagawa, Kazuhiko
Nishio, Kazuto
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Kindai Univ, Fac Med, Osakasayama, Japan
[4] Natl Canc Ctr Hosp East, Dept Data Sci, Kashiwa, Chiba, Japan
[5] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
[6] Hiroshima Citizens Hosp, Hiroshima, Japan
[7] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[8] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[9] Shizuoka Canc Ctr, Shizuoka, Sunto Gun, Japan
[10] Natl Hosp Org Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[11] Hiroshima Univ, Hiroshima, Japan
[12] Chiba Univ, Grad Sch Med, Chiba, Japan
[13] Osaka Int Canc Inst, Osaka, Japan
[14] Juntendo Univ, Div Resp Med, Fac Med, Tokyo, Japan
[15] Grad Sch Med, Tokyo, Japan
[16] Tokyo Med Univ, Tokyo, Japan
[17] Suita Tokushukai Hosp, Suita, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8524
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report
    Owada-Ozaki, Yuki
    Muto, Satoshi
    Takagi, Hironori
    Inoue, Takuya
    Watanabe, Yuzuru
    Fukuhara, Mitsuro
    Yamaura, Takumi
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Ohsugi, Jun
    Hoshino, Mika
    Shio, Yutaka
    Nanamiya, Hideaki
    Imai, Jun-ichi
    Isogai, Takao
    Watanabe, Shinya
    Suzuki, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1217 - 1221
  • [2] Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer
    Devarakonda, Siddhartha
    Rotolo, Federico
    Tsao, Ming-Sound
    Lanc, Irena
    Brambilla, Elisabeth
    Masood, Ashiq
    Olaussen, Ken A.
    Fulton, Robert
    Sakashita, Shingo
    McLeer-Florin, Anne
    Ding, Keyue
    Le Teuff, Gwenael
    Shepherd, Frances A.
    Pignon, Jean-Pierre
    Graziano, Stephen L.
    Kratzke, Robert
    Soria, Jean-Charles
    Seymour, Lesley
    Govindan, Ramaswamy
    Michiels, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30) : 2995 - +
  • [3] Genetic and Epigenetic Alterations are Associated with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Cai, L.
    Bai, H.
    Wang, Z.
    Wang, S.
    Duan, J.
    Gao, S.
    He, J.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [4] Impact of EGFR mutation analysis in non-small cell lung cancer
    Yamamoto, Hiromasa
    Toyooka, Shinichi
    Mitsudomi, Tetsuya
    LUNG CANCER, 2009, 63 (03) : 315 - 321
  • [5] Impact of EGFR mutation and types of treatment on the longitudinal recurrence risk in patients with completely resected non-small cell lung cancer: A combined analysis of two phase III studies (JIPANG and IMPACT)
    Akamatsu, Hiroaki
    Nishikawa, Tomomi
    Misumi, Toshihiro
    Aoki, Tadashi
    Shoda, Hiroyasu
    Yamashita, Motohiro
    Sakakura, Noriaki
    Daga, Haruko
    Sugawara, Shunichi
    Okishio, Kyoichi
    Kenmotsu, Hirotsugu
    Yamamoto, Nobuyuki
    Tada, Hirohito
    Tsuboi, Masahiro
    Mitsudomi, Tetsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
    Sorotsky, H.
    Cabanero, M.
    Moskovitz, M.
    Weiss, J.
    Pintilie, M.
    Leighl, N.
    Bradbury, P.
    Liu, G.
    Kia, A.
    Pugh, T.
    Torti, D.
    Torchia, J.
    Tsao, M.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S921 - S921
  • [7] Tumor mutation burden as emerging biomarker in non-small cell lung cancer and beyond
    Fischer, Rieke N.
    Wolf, Juergen
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S770 - S773
  • [8] Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
    Cai, Liangliang
    Bai, Hua
    Duan, Jianchun
    Wang, Zhijie
    Gao, Shugeng
    Wang, Di
    Wang, Shuhang
    Jiang, Jun
    Han, Jiefei
    Tian, Yanhua
    Zhang, Xue
    Ye, Hao
    Li, Minghui
    Huang, Bingding
    He, Jie
    Wang, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutation
    Kodama, Hiroaki
    Kenmotsu, Hirotsugu
    Kawabata, Takanori
    Notsu, Akifumi
    Yabe, Michitoshi
    Nishioka, Naoya
    Miyawaki, Eriko
    Miyawaki, Taichi
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    CANCER MEDICINE, 2021, 10 (21): : 7503 - 7513
  • [10] The predictive value of serum tumor markers for EGFR mutation in non-small cell lung cancer patients with non-stage IA
    Du, Wenxing
    Qiu, Tong
    Liu, Hanqun
    Liu, Ao
    Wu, Zhe
    Sun, Xiao
    Qin, Yi
    Su, Wenhao
    Huang, Zhangfeng
    Yun, Tianxiang
    Jiao, Wenjie
    HELIYON, 2024, 10 (09)
12345